Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders

NACompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

June 15, 2018

Study Completion Date

July 10, 2019

Conditions
Panic DisorderAgoraphobiaSocial Anxiety DisorderGeneralized Anxiety Disorder
Interventions
BEHAVIORAL

Transdiagnostic Cognitive-Behavioral Therapy

Treatment in the Transdiagnostic CBT condition will consist of 12 weekly 2-hour sessions following the manualized treatment protocol including psychoeducation, cognitive restructuring, exposure and relapse prevention.

Trial Locations (3)

H7M3L9

Centre intégré de santé et de services sociaux de Laval, Laval

J1G1B1

Centre intégré universitaire de santé et de services sociaux de l'Estrie, Sherbrooke

G1C3S2

Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Estrie University Integrated Health and Social Services Center - University Hospital of Sherbrooke

OTHER

collaborator

CISSS de Laval

UNKNOWN

collaborator

Integrated University Health and Social Services Center of the Capitale-Nationale

OTHER

lead

Université de Sherbrooke

OTHER

NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders | Biotech Hunter | Biotech Hunter